You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

RUBRAMIN PC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Rubramin Pc, and what generic alternatives are available?

Rubramin Pc is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in RUBRAMIN PC is cyanocobalamin. There are nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Rubramin Pc

A generic version of RUBRAMIN PC was approved as cyanocobalamin by PADAGIS ISRAEL on September 9th, 2020.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for RUBRAMIN PC?
  • What are the global sales for RUBRAMIN PC?
  • What is Average Wholesale Price for RUBRAMIN PC?
Summary for RUBRAMIN PC
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 2
Patent Applications: 57
DailyMed Link:RUBRAMIN PC at DailyMed
Drug patent expirations by year for RUBRAMIN PC

US Patents and Regulatory Information for RUBRAMIN PC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb RUBRAMIN PC cyanocobalamin INJECTABLE;INJECTION 006799-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bristol Myers Squibb RUBRAMIN PC cyanocobalamin INJECTABLE;INJECTION 006799-004 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bristol Myers Squibb RUBRAMIN PC cyanocobalamin INJECTABLE;INJECTION 006799-010 Apr 28, 1988 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.